Skip to content

Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery

A Comparative Study Between Levobupivacaine 0.5% and Ropivacaine 0.75% in Patients Undergoing Spinal Anaesthesia for Lower Limb Orthopaedic Surgery.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02201784
Enrollment
60
Registered
2014-07-28
Start date
2012-12-31
Completion date
2014-01-31
Last updated
2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Surgery

Keywords

Subarachnoid block, intrathecal, spinal anesthesia, isobaric, levobupivacaine, ropivacaine

Brief summary

The purpose of this study is to compare the effects of two intrathecally administered drugs:0.5% levobupivacaine and0.75%Ropivacaine in spinal anesthesia

Detailed description

Bupivacaine is a highly cardiotoxic drug and also produces prolonged motor blockade.The newer drugs levobupivacaine and ropivacaine being comparatively less cardio and neurotoxic are preferred now a days.So, we conducted this prospective, randomized double blind study with an aim of comparing the efficacy and characteristics of these drugs.

Interventions

DRUGLevobupivacaine

Comparison of Equipotent doses

DRUGRopivacaine

Comparison of equipotent doses

Sponsors

Aligarh Muslim University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. American Society of Anesthesiologists (ASA) class I & II patients of either sex 2. Age between 18-60 years

Exclusion criteria

1. Patient's refusal. 2. Patients who have contraindications to spinal anaesthesia / Local anaesthetic drugs. 3. Patients having h/o diabetes, neurological and musculoskeletal diseases.

Design outcomes

Primary

MeasureTime frameDescription
Duration of Analgesia8 hoursDefined as time for first analgesic request by the patient

Secondary

MeasureTime frameDescription
Onset of Sensory Block at T1030 minuteslevel of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned.
Median Maximum Level of Sensory Blockade8 hourslevel of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned.
Onset of Motor Block to Bromage38 hoursMotor block in the lower limbs was graded according to the modified Bromage scale (Grade 0 = No motor block, Grade 1 = Inability to raise extended leg, able to move knees and feet, Grade 2 = Inability to raise extended leg and move knee, able to move feet, Grade 3 = Complete motor block of the lower limbs). Thereafter, It was performed every 5 minutes till the attainment of MB grade 3 followed by every 30 minutes until complete recovery (MB grade0).
Duration of Motor Block8 hoursTime when the Bromage score will be back to zero
Time to Maximum Cephalic Spread of Sensory Block8 hours

Other

MeasureTime frameDescription
Pulse Rate, Mean Arterial Pressure, SpO28 hoursIntragroup and intergroup variation compared

Countries

India

Participant flow

Recruitment details

jawaharlal nehru medical college and hospital

Pre-assignment details

Patients who met any of the exclusion criteria or those who did not gave consent were excluded.

Participants by arm

ArmCount
Levobupivacaine 0.5%
intrathecal administration of 15 mg of Levobupivacaine 0.5% Levobupivacaine: Comparison of Equipotent doses
30
Ropivacaine 0.75%
intrathecal administration of 22.5 mg of Ropivacaine 0.75% Ropivacaine: Comparison of equipotent doses
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyFailure to achieve adequate block20

Baseline characteristics

CharacteristicTotalLevobupivacaine 0.5%Ropivacaine 0.75%
Age, Continuous37 years
STANDARD_DEVIATION 16
38 years
STANDARD_DEVIATION 17
35 years
STANDARD_DEVIATION 16
Region of Enrollment
India
60 participants30 participants30 participants
Sex: Female, Male
Female
13 Participants6 Participants7 Participants
Sex: Female, Male
Male
47 Participants24 Participants23 Participants
Weight55.5 kg
STANDARD_DEVIATION 8.27
53.83 kg
STANDARD_DEVIATION 9.44
57.17 kg
STANDARD_DEVIATION 6.65

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
11 / 3013 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Duration of Analgesia

Defined as time for first analgesic request by the patient

Time frame: 8 hours

ArmMeasureValue (MEAN)Dispersion
Levobupivacaine 0.5%Duration of Analgesia309.83 minutesStandard Deviation 36.45
Ropivacaine 0.75%Duration of Analgesia249.50 minutesStandard Deviation 22.83
Secondary

Duration of Motor Block

Time when the Bromage score will be back to zero

Time frame: 8 hours

ArmMeasureValue (MEAN)Dispersion
Levobupivacaine 0.5%Duration of Motor Block290.50 minutesStandard Deviation 34.67
Ropivacaine 0.75%Duration of Motor Block222.50 minutesStandard Deviation 23
Secondary

Median Maximum Level of Sensory Blockade

level of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned.

Time frame: 8 hours

Secondary

Onset of Motor Block to Bromage3

Motor block in the lower limbs was graded according to the modified Bromage scale (Grade 0 = No motor block, Grade 1 = Inability to raise extended leg, able to move knees and feet, Grade 2 = Inability to raise extended leg and move knee, able to move feet, Grade 3 = Complete motor block of the lower limbs). Thereafter, It was performed every 5 minutes till the attainment of MB grade 3 followed by every 30 minutes until complete recovery (MB grade0).

Time frame: 8 hours

ArmMeasureValue (MEAN)Dispersion
Levobupivacaine 0.5%Onset of Motor Block to Bromage312.17 minutesStandard Deviation 4.09
Ropivacaine 0.75%Onset of Motor Block to Bromage37.83 minutesStandard Deviation 2.84
Secondary

Onset of Sensory Block at T10

level of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned.

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Levobupivacaine 0.5%Onset of Sensory Block at T1013.50 minutesStandard Deviation 4.94
Ropivacaine 0.75%Onset of Sensory Block at T107.33 minutesStandard Deviation 2.54
Secondary

Time to Maximum Cephalic Spread of Sensory Block

Time frame: 8 hours

ArmMeasureValue (MEAN)Dispersion
Levobupivacaine 0.5%Time to Maximum Cephalic Spread of Sensory Block20.33 minutesStandard Deviation 5.31
Ropivacaine 0.75%Time to Maximum Cephalic Spread of Sensory Block13.17 minutesStandard Deviation 3.02
Other Pre-specified

Pulse Rate, Mean Arterial Pressure, SpO2

Intragroup and intergroup variation compared

Time frame: 8 hours

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026